1 Study Coverage 1.1 Amebiasis Therapeutics Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Amebiasis Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Amebiasis Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Amebiasis Therapeutics Market Size for the Year 2017-2028 1.3 Amebiasis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Amebiasis Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Amebiasis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Amebiasis Therapeutics Market Dynamics 1.4.1 Amebiasis Therapeutics Industry Trends 1.4.2 Amebiasis Therapeutics Market Drivers 1.4.3 Amebiasis Therapeutics Market Challenges 1.4.4 Amebiasis Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Amebiasis Therapeutics by Type 2.1 Amebiasis Therapeutics Market Segment by Type 2.1.1 Metronidazole 2.1.2 Paromomycin 2.1.3 Tinidazole 2.1.4 Other 2.2 Global Amebiasis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Amebiasis Therapeutics Market Size by Type (2017-2028) 2.4 United States Amebiasis Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Amebiasis Therapeutics Market Size by Type (2017-2028) 3 Amebiasis Therapeutics by Application 3.1 Amebiasis Therapeutics Market Segment by Application 3.1.1 Hospital 3.1.2 Pharmacy 3.2 Global Amebiasis Therapeutics Market Size by Application (2017, 2022 & 2028) 3.3 Global Amebiasis Therapeutics Market Size by Application (2017-2028) 3.4 United States Amebiasis Therapeutics Market Size by Application (2017, 2022 & 2028) 3.5 United States Amebiasis Therapeutics Market Size by Application (2017-2028) 4 Global Amebiasis Therapeutics Competitor Landscape by Company 4.1 Global Amebiasis Therapeutics Market Size by Company 4.1.1 Top Global Amebiasis Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Amebiasis Therapeutics Revenue by Player (2017-2022) 4.2 Global Amebiasis Therapeutics Concentration Ratio (CR) 4.2.1 Amebiasis Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Amebiasis Therapeutics in 2021 4.2.3 Global Amebiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Amebiasis Therapeutics Headquarters, Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Amebiasis Therapeutics Headquarters and Area Served 4.3.2 Global Amebiasis Therapeutics Companies Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Amebiasis Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Amebiasis Therapeutics Market Size by Company 4.5.1 Top Amebiasis Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Amebiasis Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Amebiasis Therapeutics Market Size by Region 5.1 Global Amebiasis Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Amebiasis Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Amebiasis Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Amebiasis Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Amebiasis Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Amebiasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Amebiasis Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Amebiasis Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Amebiasis Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Amebiasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Amebiasis Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Amebiasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Amebiasis Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Amebiasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Dr. Reddy’s Laboratories 7.1.1 Dr. Reddy’s Laboratories Company Details 7.1.2 Dr. Reddy’s Laboratories Business Overview 7.1.3 Dr. Reddy’s Laboratories Amebiasis Therapeutics Introduction 7.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2017-2022) 7.1.5 Dr. Reddy’s Laboratories Recent Development 7.2 Mission Pharmacal 7.2.1 Mission Pharmacal Company Details 7.2.2 Mission Pharmacal Business Overview 7.2.3 Mission Pharmacal Amebiasis Therapeutics Introduction 7.2.4 Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2017-2022) 7.2.5 Mission Pharmacal Recent Development 7.3 Aceto Corporation 7.3.1 Aceto Corporation Company Details 7.3.2 Aceto Corporation Business Overview 7.3.3 Aceto Corporation Amebiasis Therapeutics Introduction 7.3.4 Aceto Corporation Revenue in Amebiasis Therapeutics Business (2017-2022) 7.3.5 Aceto Corporation Recent Development 7.4 Mylan Pharmaceuticals 7.4.1 Mylan Pharmaceuticals Company Details 7.4.2 Mylan Pharmaceuticals Business Overview 7.4.3 Mylan Pharmaceuticals Amebiasis Therapeutics Introduction 7.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) 7.4.5 Mylan Pharmaceuticals Recent Development 7.5 Impax Laboratories 7.5.1 Impax Laboratories Company Details 7.5.2 Impax Laboratories Business Overview 7.5.3 Impax Laboratories Amebiasis Therapeutics Introduction 7.5.4 Impax Laboratories Revenue in Amebiasis Therapeutics Business (2017-2022) 7.5.5 Impax Laboratories Recent Development 7.6 Pfizer 7.6.1 Pfizer Company Details 7.6.2 Pfizer Business Overview 7.6.3 Pfizer Amebiasis Therapeutics Introduction 7.6.4 Pfizer Revenue in Amebiasis Therapeutics Business (2017-2022) 7.6.5 Pfizer Recent Development 7.7 Sanofi 7.7.1 Sanofi Company Details 7.7.2 Sanofi Business Overview 7.7.3 Sanofi Amebiasis Therapeutics Introduction 7.7.4 Sanofi Revenue in Amebiasis Therapeutics Business (2017-2022) 7.7.5 Sanofi Recent Development 7.8 Lupin Pharmaceuticals 7.8.1 Lupin Pharmaceuticals Company Details 7.8.2 Lupin Pharmaceuticals Business Overview 7.8.3 Lupin Pharmaceuticals Amebiasis Therapeutics Introduction 7.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) 7.8.5 Lupin Pharmaceuticals Recent Development 7.9 Glenmark Pharmaceuticals 7.9.1 Glenmark Pharmaceuticals Company Details 7.9.2 Glenmark Pharmaceuticals Business Overview 7.9.3 Glenmark Pharmaceuticals Amebiasis Therapeutics Introduction 7.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) 7.9.5 Glenmark Pharmaceuticals Recent Development 7.10 Sun Pharmaceutical 7.10.1 Sun Pharmaceutical Company Details 7.10.2 Sun Pharmaceutical Business Overview 7.10.3 Sun Pharmaceutical Amebiasis Therapeutics Introduction 7.10.4 Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2017-2022) 7.10.5 Sun Pharmaceutical Recent Development 7.11 Heritage Pharmaceuticals 7.11.1 Heritage Pharmaceuticals Company Details 7.11.2 Heritage Pharmaceuticals Business Overview 7.11.3 Heritage Pharmaceuticals Amebiasis Therapeutics Introduction 7.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) 7.11.5 Heritage Pharmaceuticals Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Amebiasis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Amebiasis Therapeutics Market Trends Table 3. Amebiasis Therapeutics Market Drivers Table 4. Amebiasis Therapeutics Market Challenges Table 5. Amebiasis Therapeutics Market Restraints Table 6. Global Amebiasis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Amebiasis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Amebiasis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Amebiasis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Amebiasis Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Amebiasis Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Amebiasis Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Amebiasis Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Amebiasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Therapeutics as of 2021) Table 15. Top Players of Amebiasis Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Amebiasis Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Amebiasis Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Amebiasis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Amebiasis Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Amebiasis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Amebiasis Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Amebiasis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Amebiasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Amebiasis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Amebiasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Amebiasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Amebiasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Dr. Reddy’s Laboratories Company Details Table 31. Dr. Reddy’s Laboratories Business Overview Table 32. Dr. Reddy’s Laboratories Amebiasis Therapeutics Product Table 33. Dr. Reddy’s Laboratories Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 34. Dr. Reddy’s Laboratories Recent Development Table 35. Mission Pharmacal Company Details Table 36. Mission Pharmacal Business Overview Table 37. Mission Pharmacal Amebiasis Therapeutics Product Table 38. Mission Pharmacal Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 39. Mission Pharmacal Recent Development Table 40. Aceto Corporation Company Details Table 41. Aceto Corporation Business Overview Table 42. Aceto Corporation Amebiasis Therapeutics Product Table 43. Aceto Corporation Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 44. Aceto Corporation Recent Development Table 45. Mylan Pharmaceuticals Company Details Table 46. Mylan Pharmaceuticals Business Overview Table 47. Mylan Pharmaceuticals Amebiasis Therapeutics Product Table 48. Mylan Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 49. Mylan Pharmaceuticals Recent Development Table 50. Impax Laboratories Company Details Table 51. Impax Laboratories Business Overview Table 52. Impax Laboratories Amebiasis Therapeutics Product Table 53. Impax Laboratories Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 54. Impax Laboratories Recent Development Table 55. Pfizer Company Details Table 56. Pfizer Business Overview Table 57. Pfizer Amebiasis Therapeutics Product Table 58. Pfizer Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 59. Pfizer Recent Development Table 60. Sanofi Company Details Table 61. Sanofi Business Overview Table 62. Sanofi Amebiasis Therapeutics Product Table 63. Sanofi Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 64. Sanofi Recent Development Table 65. Lupin Pharmaceuticals Company Details Table 66. Lupin Pharmaceuticals Business Overview Table 67. Lupin Pharmaceuticals Amebiasis Therapeutics Product Table 68. Lupin Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 69. Lupin Pharmaceuticals Recent Development Table 70. Glenmark Pharmaceuticals Company Details Table 71. Glenmark Pharmaceuticals Business Overview Table 72. Glenmark Pharmaceuticals Amebiasis Therapeutics Product Table 73. Glenmark Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 74. Glenmark Pharmaceuticals Recent Development Table 75. Sun Pharmaceutical Company Details Table 76. Sun Pharmaceutical Business Overview Table 77. Sun Pharmaceutical Amebiasis Therapeutics Product Table 78. Sun Pharmaceutical Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 79. Sun Pharmaceutical Recent Development Table 80. Heritage Pharmaceuticals Company Details Table 81. Heritage Pharmaceuticals Business Overview Table 82. Heritage Pharmaceuticals Amebiasis Therapeutics Product Table 83. Heritage Pharmaceuticals Revenue in Amebiasis Therapeutics Business (2017-2022) & (US$ Million) Table 84. Heritage Pharmaceuticals Recent Development Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Amebiasis Therapeutics Product Picture Figure 2. Global Amebiasis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Amebiasis Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Amebiasis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Amebiasis Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Amebiasis Therapeutics Market Share in Global 2017-2028 Figure 7. Amebiasis Therapeutics Report Years Considered Figure 8. Product Picture of Metronidazole Figure 9. Product Picture of Paromomycin Figure 10. Product Picture of Tinidazole Figure 11. Product Picture of Other Figure 12. Global Amebiasis Therapeutics Market Share by Type in 2022 & 2028 Figure 13. Global Amebiasis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Amebiasis Therapeutics Market Share by Type (2017-2028) Figure 15. United States Amebiasis Therapeutics Market Share by Type in 2022 & 2028 Figure 16. United States Amebiasis Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Amebiasis Therapeutics Market Share by Type (2017-2028) Figure 18. Product Picture of Hospital Figure 19. Product Picture of Pharmacy Figure 20. Global Amebiasis Therapeutics Market Share by Application in 2022 & 2028 Figure 21. Global Amebiasis Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Amebiasis Therapeutics Market Share by Application (2017-2028) Figure 23. United States Amebiasis Therapeutics Market Share by Application in 2022 & 2028 Figure 24. United States Amebiasis Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Amebiasis Therapeutics Market Share by Application (2017-2028) Figure 26. North America Amebiasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Amebiasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Amebiasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Amebiasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Amebiasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. U.A.E Amebiasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 55. Mission Pharmacal Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 56. Aceto Corporation Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 57. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 58. Impax Laboratories Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 59. Pfizer Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 60. Sanofi Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 61. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 62. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 63. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 64. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Therapeutics Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Dr. Reddy’s Laboratories Mission Pharmacal Aceto Corporation Mylan Pharmaceuticals Impax Laboratories Pfizer Sanofi Lupin Pharmaceuticals Glenmark Pharmaceuticals Sun Pharmaceutical Heritage Pharmaceuticals